CoChat

Rapid On-Site Evaluation of Endobronchial Ultrasound–Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society

Open access
Jain, Deepali, Allen, Timothy Craig, Aisner, Dara L., Beasley, Mary Beth, Cagle, Philip T., Capelozzi, Vera Luiza, Hariri, Lida P., Lantuejoul, Sylvie, Miller, Ross, Mino-Kenudson, Mari, Monaco, Sara E., Moreira, Andre, Raparia, Kirtee, Rekhtman, Natasha, Roden, Anja Christiane, Roy-Chowdhuri, Sinchita, da Cunha Santos, Gilda, Thunnissen, Erik, Troncone, Giancarlo, Vivero, Marina · 2018 · Archives of Pathology & Laboratory Medicine
Cited by 183

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Context.—: Endobronchial ultrasound–guided transbronchial needle aspiration (EBUS-TBNA) has emerged as a very useful tool in the field of diagnostic respiratory cytology. Rapid on-site evaluation (ROSE) of EBUS-TBNA not only has the potential to improve diagnostic yield of the procedure but also to triage samples for predictive molecular testing to guide personalized treatments for lung cancer. Objective.—: To provide an overview of the current status of the literature regarding ROSE of EBUS-TBNA in the diagnosis of lung cancer. Data Sources.—: An electronic literature search in PubMed and Google databases was performed using the following key words: cytology, lung cancer, on-site evaluation, rapid on-site evaluation, and ROSE EBUS-TBNA. Only articles published in English were included in this review. Conclusions.—: Rapid on-site evaluation can ensure that the targeted lesion is being sampled and can enable appropriate specimen triage. If available, it should be used with EBUS-TBNA in the diagnosis of lung cancer because it can minimize repeat procedures for additional desired testing (ie, molecular studies). Some studies have shown that ROSE does not adversely affect the number of aspirations, total procedure time of EBUS-TBNA, or the rate of postprocedure complications; it is also helpful in providing a preliminary diagnosis that can reduce the number of additional invasive procedures, such as mediastinoscopy. As EBUS technology continues to evolve, our knowledge of the role of ROSE in EBUS-TBNA for the diagnosis of lung cancer will also continue to grow and evolve.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5858/arpa.2017-0114-sa

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 183

Metadata

Authors
Jain, D., Allen, T. C., Aisner, D. L., Beasley, M. B., Cagle, P. T., Capelozzi, V. L., Hariri, L. P., Lantuejoul, S., Miller, R., Mino-Kenudson, M., Monaco, S. E., Moreira, A., Raparia, K., Rekhtman, N., Roden, A. C., Roy-Chowdhuri, S., da Cunha Santos, G., Thunnissen, E., Troncone, G., & Vivero, M.
Venue
Archives of Pathology & Laboratory Medicine
Published
2017-06-22
Volume
142
Issue
2
Pages
253-262
ISSN
  • 0003-9985 (ISSN-L)
  • 1543-2165
OpenAlex
W2661673758
Cited by
183
References
1
FWCI
12.15
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rapid On-Site Evaluation of Endobronchial Ultrasound–Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society. https://app.cochat.ai/papers/10.5858/arpa.2017-0114-sa
The paper
Jain, D., Allen, T. C., Aisner, D. L., Beasley, M. B., Cagle, P. T., Capelozzi, V. L., Hariri, L. P., Lantuejoul, S., Miller, R., Mino-Kenudson, M., Monaco, S. E., Moreira, A., Raparia, K., Rekhtman, N., Roden, A. C., Roy-Chowdhuri, S., da Cunha Santos, G., Thunnissen, E., Troncone, G., & Vivero, M. (2018). Rapid On-Site Evaluation of Endobronchial Ultrasound–Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society. Archives of Pathology & Laboratory Medicine. https://doi.org/10.5858/arpa.2017-0114-sa

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.